Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Moderna Inc shares valued at $12,771 were sold by Hoge Stephen on Nov 11 ’24. At $46.10 per share, Hoge Stephen sold 277 shares. The insider’s holdings dropped to 1,443,248 shares worth approximately $55.2 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Hoge Stephen purchased 277 shares, netting a total of over 12,771 in proceeds.
Before that, Mock James M had sold 715 shares from its account. In a trade valued at $42,986, the Chief Financial Officer traded Moderna Inc shares for $60.12 each. Upon closing the transaction, the insider’s holdings decreased to 715 shares, worth approximately $0.36 million.
As published in their initiating research note from Berenberg on November 19, 2024, Moderna Inc [MRNA] has been a Hold and the price target has been revised to $42. Analysts at HSBC Securities upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in mid November. As of November 15, 2024, Wolfe Research has initiated its “an Underperform” rating for MRNA. Earlier on October 17, 2024, Bernstein initiated its rating. Their recommendation was “a Mkt perform” for MRNA stock.
Analyzing MRNA Stock Performance
During the last five days, there has been a drop of approximately -3.82%. Over the course of the year, Moderna Inc shares have dropped approximately -61.54%. Shares of the company reached a 52-week high of $170.47 on 05/24/24 and a 52-week low of $35.80 on 11/15/24. A 50-day SMA is recorded $55.50, while a 200-day SMA reached $96.37. Nevertheless, trading volume fell to 8.94 million shares from 7.34 million shares the previous day.
Support And Resistance Levels for Moderna Inc (MRNA)
According to the 24-hour chart, there is a support level at 36.53, which, if violated, would cause prices to drop to 34.82. In the upper region, resistance lies at 39.39. The next price resistance is at 40.54. RSI (Relative Strength Index) is 25.42 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -6.27, which suggests the price will decrease in the coming days. Percent R is at 88.27%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
